Biocom welcomes Zachary Hornby, CEO of Callio Therapeutics, and Kevin Marks, chief legal officer of @parkerici, to our board of directors. Their combined expertise will help advance innovation and strengthen our life science community.
Read more: bit.ly/4iPGTaD
Join Biocom on December 8 at Osa Rooftop in Pasadena for the Greater LA | A Year in Celebration. Connect with colleagues and industry peers over delicious bites, specialty cocktails and live music as we celebrate California's life science community and look ahead to another year of progress.
Register today: bit.ly/4jnhuoQ
Two networks. More opportunity. Biocom’s partnership with @OctaneOC connects medtech innovators to capital opportunities, commercialization support and expanded industry networks.
Explore membership: bit.ly/4zPDUV9#MedTech
Our member @UCSDExtStudies offers hands-on training in RNA sequencing analysis through its Transcriptomics Bioinformatics for Precision Medicine course.
Learn more: bit.ly/4j2TDcT
It's #NewMemberMonday! #AthensBioscience produces and tests purified native proteins and custom protein solutions across microgram-to-kilogram scales to support reproducible scientific research. @CGT_Global sources and isolates human biospecimens, specialized blood products and primary cells from healthy and diseased donors to accelerate drug discovery and clinical trials. #ElenaeTherapeutics combines AI drug design with targeted delivery strategies to develop RNA medicines for internal programs and partners. #HokanBio manages operations and long-term preservation infrastructure for natural history specimen collections, rescuing and warehousing at-risk biological samples to support environmental research. #MoktraBio develops targeted therapies that remove proteins that cause inflammation. #RASIRC converts liquids into reactive vapors for semiconductor and adjacent markets, enabling atomic-scale film growth at low temperatures within high-aspect-ratio structures.
Mentor registration for the 2027 cohort of @BiocomInstitute Life Science Career Fellowship is closing soon. California life science professionals at the managerial level or above can still secure a spot to guide emerging talent, sharpen their leadership skills and connect with regional peers dedicated to strengthening the life science workforce. With a flexible 15-hour hybrid commitment from January through June, mentors help fellows build career readiness — in the 2026 cohort, 95% of mentors agreed their fellows left fully prepared to enter the industry.
Don’t miss the opportunity to shape the next generation of life science leaders.
Sign up today: bit.ly/3UTiZlf
Don’t miss Biocom's Bay Area Member Appreciation Holiday Party & Catalyst Award Ceremony on December 2. Enjoy festive refreshments, connect with fellow life science professionals and help us celebrate the outstanding individuals advancing human health. Learn more: bit.ly/4zjOXFx
This week in Bay Area life sciences: #AdjuviaTherapeutics initiates a Phase 1 clinical trial of ATI-105 for the treatment of Friedreich’s ataxia. @Coherus_Bio presents compelling interim clinical data for tagmokitug in the treatment of esophageal cancer and outlines the therapy's development path. @novotechCRO offers an on-demand webinar exploring how strategic market selection and regulatory planning across the Asia-Pacific region can support global oncology drug development. Subscribe to receive the next newsletter in your inbox: bit.ly/40rlR8a
This week in San Diego life sciences: @DCNDiagnostics acquires BioSouthTech to expand its biospecimen collection network and improve access to diverse patient populations for drug and diagnostic research. @dexcom launches its "A Letter to Diabetes" campaign to collect stories from the global diabetes patient community. @VivoSimSolana and @chemveda collaborate to advance AI-designed drug candidates toward human testing. Subscribe to receive the next newsletter in your inbox: bit.ly/4iqn5b1
Is there such a thing as engaging patients too early?
For life science companies, the focus is often on advancing the science, securing funding and reaching the next development milestone. So where does patient advocacy fit when a technology or therapy is still in its earliest stages?
Patient advocacy organizations can help companies understand unmet needs, inform research priorities and identify challenges that might otherwise be overlooked.
Biocom’s Patient Advocacy Initiative brings industry and patient communities together earlier and more effectively.
Join us for a virtual conversation with industry leaders and patient advocates about the opportunities and practical considerations of engaging patient communities throughout development.
December 1 | 11 a.m. PST | Virtual
Register bit.ly/4C7IFLZ#PatientAdvocacy#RareDisease#LifeSciences
2026 Biocom Catalyst Award winner Evan Feinberg of @genesismolai uses AI and physics-based simulation to advance drug discovery for challenging targets. Read his story: bit.ly/4iHw8XI#BiocomCatalystAwards
Congratulations to Biocom member Pictor on being named Proteomics Company of the Year in the 2026 BioTech Breakthrough Awards! The recognition highlights advances in its targeted proteomics platform, research and collaborations.
Learn more: bit.ly/4ApmCOT
🚨 Attention life science innovators: only 1 day remaining to apply to present at our Global Partnering & Investor Conference. Don't miss this opportunity to showcase your latest innovations and gain additional exposure to over 600 potential investors and strategic partners in attendance. Apply to present at #BiocomGPIC by tomorrow, November 13: bit.ly/4zMwYZs
Biocom member @TaylorTalk (Taylor Design) is partnering with @UCSF to modernize labs at its Children’s Research Center, creating flexible, collaborative spaces that advance pediatric biomedical research while preserving the building’s historic character. Learn more: bit.ly/4fosdNn